Vaccine Therapy in Treating Patients With Stage IV Head and Neck Cancer

Phase 1 Completed National Institute on Deafness and Other Communication Disorders (NIDCD)

Treatment

Summary

RATIONALE: Vaccines may make the body build an immune response to kill tumor cells. PURPOSE: Phase I trial to study the effectiveness of vaccine therapy in treating patients who have stage IV head and neck cancer.

Timeline

Start: 2001-06
Primary completion: —
Completion: —

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	recombinant fowlpox-TRICOM vaccine	Vaccine	—	Other

Vaccine Therapy in Treating Patients With Stage IV Head and Neck Cancer

Summary

Timeline

Drugs

Indications